2Gluckman E,Broxmeyer HE,Auerbach AD,et al.Hematopoletic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling[J].N Engl J Med,1989,321:1174-1178.
5Kiss J E ,Rybka W B ,Winkelstein A,et al .Relationship of CD34+ cell dose to early and late he matopoiesis following autologous peripheral blood seem cell transplantation[J].Bone Marrow Transplant,1997,19(4):303.
6Kurtzberg J,Graham TW,Casei J ,et al .The use of umbilical Cord blood in mismatched related and unrelated hematopoietic stem cell transplantation[J] .Blood Cells,1994,20:275-284.
8Kurtzberg J,Laughlin M,Graham ML,et al,placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients[J] .N Engl J Med,1996,335:157-166.
9Xu R,Reems JA. Unibilical cord blood progeny cells that retain CD34+ phenotype after ex vivo expansion have less engraftment protential than unexpanded CD34+ cells[J].Transfusion,2001,41:213-218.
1[1]Yamane T, Hino M, Ohta K, et al. Allogeneic peripheral blood stem cell transplantation. Rinsho Byori, 1999, 110(Suppl) :85.
2[2]Takenaka K, Harada M. Nationwide survey of allogeneic pe ripheral blood stem cell transplantation in Japan. Rinsho Ketsue ki, 1999, 40 (6) :451.
3[3]Harada M. Allogeneic peripheral blood stem cell transplantation as an alternative to allogeneic bone marrow transplanta tion. Intern Med, 1998, 37 (12) :1001.
4[4]Lebel- Medeiros N J, Fitz P A. Rationale, process, and nu tritional implications of peripheral blood stem cell transplanta tion. J Am Diet Assoc, 1998, 98 (9) : 1024.
5[5]Kiss J E, Rybka W B, Winkelstein A, et al. Relationship of CD+34 cell dose to early and late hematopoiesis following autolo gous peripheral blood stem cell transplantation. Bone Marrow Transplant, 1997, 19 (4) :303.
6[6]Sugio Y, Tokunaga Y, Nomura A, et al. Peripheral blood stem cell transplantation-practices of mobilization and har vest. Rinsho Byori, 1999, 110 (Suppl) :63.
7[7]Schiflman K, Buckner C D, Maziarz R, et al. High-dose busulfan, melphalan, and thiotepa followed by autologous pe ripheral blood stem cell transplantation in patients with aggres sive lymphoma or relapsed Hodgkin's disease. Biol Blood Mar row Transplant, 1997, 3 (5) :261.
8[8]Collby C, McAfee S L, Finkelstein D M, et al. Early vs de layed administration of G-CSF following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant, 1998,21 (10) :1005.
9[9]Hwang W L, Tsai C S, Jour J H, et al. Autologous peripheral blood stem cell transplantation using simplified procedures for collection and freezing. Chung Hua Ⅰ Hsueh Tsa Chin Taipei, 1999, 62 (8) :529.
10[10]Sampol M A, Besalduch V J, Galmes L A, et al. CD+34 cell dose and CD-33 subsets: collection and engraftment kinstics in autologous peripheral blood stem cell transplantation. Haematol ogica, 1998, 83 (6) :489.
